biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
05:39 Large trial tests whether a daily pill can slow fast-moving ALS✦05:37 More years of periods and hormone therapy tied to healthier brain vessels✦05:36 Drug-switched brain therapy tried in 3 people with hard-to-treat epilepsy✦23:40 New kind of prostate cancer drug showed promising signs, Yale team reports✦23:36 Cell therapy erased signs of hard-to-treat lymphoma in 3 of 4, maker says✦23:36 Gene fix for sickle cell freed 3 patients from transfusions, maker says✦17:43 Salt swap could prevent nearly 3 million deaths a year, model estimates✦17:40 Regrowth from a shot for patchy hair loss held after stopping, maker says✦05:39 Large trial tests whether a daily pill can slow fast-moving ALS✦05:37 More years of periods and hormone therapy tied to healthier brain vessels✦05:36 Drug-switched brain therapy tried in 3 people with hard-to-treat epilepsy✦23:40 New kind of prostate cancer drug showed promising signs, Yale team reports✦23:36 Cell therapy erased signs of hard-to-treat lymphoma in 3 of 4, maker says✦23:36 Gene fix for sickle cell freed 3 patients from transfusions, maker says✦17:43 Salt swap could prevent nearly 3 million deaths a year, model estimates✦17:40 Regrowth from a shot for patchy hair loss held after stopping, maker says
← All story threadsSTORY THREAD

Pridopidine pill for ALS.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 4, 2026
    DESIGN OF A 500-PERSON TRIAL PRESENTEDTrial underway · 500 people

    Large trial tests whether a daily pill can slow fast-moving ALS

    A 500-person study is enrolling people with early, fast-progressing ALS to see whether the pill pridopidine slows their decline and helps them live longer than a dummy pill.